Macrocyclic polyamines as a possible chemical model for histamine H2-receptors.
- 1 January 1984
- journal article
- research article
- Published by Pharmaceutical Society of Japan in CHEMICAL & PHARMACEUTICAL BULLETIN
- Vol. 32 (9) , 3569-3578
- https://doi.org/10.1248/cpb.32.3569
Abstract
An 18-membered macrocyclic hexaamine, [18]aneN6, interacts with histamine and its H2-agonist dimaprit at physiological pH to yield stable 1:1 complexes with simultaneous liberation of H+, which mimics the histamine H2-receptor-agonist interaction and the resulting gastric acid secretion. The polyamine H2-receptor model does not interact with the histamine H1-agonist 2-pyridylethylamine. The model does interact with H2-antagonists cimetidine, metiamide, famotidine and ranitidine to form more stable 1:1 complexes than with the H2-agonists, which offers a possible chemical model for the pharmacological ability of the H2-antagonists to competitively block H2-receptors and inhibit the gastric acid secretion induced by histamine. The known structural features distinguishing between histamine H1- and H2-agonist, and between histamine H2-agonist and -antagonist, are reevaluated in terms of this model.This publication has 5 references indexed in Scilit:
- A catechol receptor model by macrocyclic polyaminesJournal of the American Chemical Society, 1983
- Macromonocyclic polyamines as biological polyanion complexons. 2. Ion-pair association with phosphate and nucleotidesJournal of the American Chemical Society, 1982
- Macromonocyclic polyamines as specific receptors for tricarboxylate-cycle anionsJournal of the American Chemical Society, 1981
- Cyanoguanidine-thiourea equivalence in the development of the histamine H2-receptor antagonist, cimetidineJournal of Medicinal Chemistry, 1977
- RECEPTORS MEDIATING SOME ACTIONS OF HISTAMINEBritish Journal of Pharmacology and Chemotherapy, 1966